RDY : Summary for Dr. Reddy's Laboratories Ltd - Yahoo Finance

U.S. Markets closed

Dr. Reddy's Laboratories Limited (RDY)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
39.68+0.06 (+0.15%)
At close: 4:02PM EDT
People also watch
HDBWITIBNTTMINFY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close39.62
Open39.72
Bid39.05 x 500
Ask40.10 x 600
Day's Range39.54 - 39.99
52 Week Range39.04 - 54.73
Volume213,224
Avg. Volume302,213
Market Cap6.18B
Beta0.08
PE Ratio (TTM)45.77
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.30 (0.75%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GuruFocus.com15 hours ago

    Stocks Reach Their 3-Year Lows

    Dr. Reddy's Laboratories Ltd., Rite Aid Corp., World Fuel Services Corp. and Target Corp have reached their respective three-year lows

  • PR Newswire10 days ago

    CytoSorbents Announces CytoSorb® Partnership with Dr. Reddy's Laboratories

    MONMOUTH JUNCTION, N.J., March 16, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), manufacturer of the CytoSorb® extracorporeal blood purification therapy that reduces excessive levels of inflammatory mediators in critically-ill and cardiac surgery patients, announced today that they have entered into a partnership with Dr. Reddy's Laboratories Ltd for the South African market. Under the terms of the agreement, Dr. Reddy's has the exclusive rights to distribute CytoSorb for intensive care, cardiac surgery, and other hospital applications in South Africa.

  • PR Newswire2 months ago

    Dr. Reddy's Expands Commercial Operations in Europe

    BASEL, Switzerland, February 8, 2017 /PRNewswire/ -- Dr. Reddy's Laboratories Ltd  announced today the expansion of its commercial operations in Europe with the introduction of its portfolio of generics ...